3 enrolling by invitation. 3 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Enrolling by invitation 3 |
Follow Digestive System Neoplasms: new trials by email Literature Review of Digestive System Neoplasms trials Research Report on Digestive System Neoplasms
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Hematoporphyrin Photodynamic Therapy for Esophageal Cancer photodynamic therapy - Esophageal Cancer, Photodynamic Therapy | Phase 4 | Enrolling by invitation | Sun Yat-sen University | 198 | 2024-09-18 | 2026-05-22 |
| Atezolizumab and Bevacizumab Pre-Liver Transplantation for Patients With Hepatocellular Carcinoma Beyond Milan Criteria Atezolizumab, Bevacizumab - Hepatocellular Carcinoma, Hepatocellular Cancer | Phase 4 | Enrolling by invitation | The Methodist Hospital Research Institute | 24 | 2023-01-30 | 2026-10-08 |
| Safety and Efficacy of Everolimus Treatment in Liver Transplantation for Liver Cancer Everolimus, Tacrolimus, Myfortic - Carcinoma, Hepatocellular | Phase 4 | Enrolling by invitation | Baylor Research Institute | 336 | 2014-03-01 | 2026-01-27 |
Carcinoma, Hepatocellular (2) · Esophageal Neoplasms (1) · Liver Neoplasms (1)
Digestive System Diseases (3) · Neoplasms (3) · Neoplasms by Site (3) · Adenocarcinoma (2) · Carcinoma (2) · Liver Diseases (2) · Neoplasms by Histologic Type (2) · Neoplasms, Glandular and Epithelial (2) · Esophageal Diseases (1) · Gastrointestinal Diseases (1) · Gastrointestinal Neoplasms (1) · Head and Neck Neoplasms (1) · Liver Neoplasms (1)
Azathioprine (1) · Bevacizumab (1) · Everolimus (1) · Mycophenolic Acid (1) · Photochemotherapy (1) · Tacrolimus (1) · atezolizumab (1)
Baylor Research Institute (1) · Sun Yat-sen University (1) · The Methodist Hospital Research Institute (1)
United States (2) · Canada (1) · China (1)